BAYER AKTIENGESELLSCHAFT (incorporated in the Federal Republic of Germany) as Issuer and as Guarantor for Notes issued by
|
|
- Franklin Daniel
- 7 years ago
- Views:
Transcription
1 Second Supplement dated July 29, 2016 to the Debt Issuance Programme Prospectus dated March 31, 2016 This document constitutes a supplement (the Supplement) within the meaning of Article 16(1) of Directive 2003/71/EC of the European Parliament and of the Council of November 4, 2003, as amended (the Prospectus Directive) and should be read in conjunction with the four base prospectuses, as supplemented by the supplement dated May 2, 2016 (the First Supplement): (i) the base prospectus of Bayer Aktiengesellschaft in respect of non-equity securities within the meaning of Art. 22 No. 6 (4) of the Commission Regulation (EC) No. 809/2004 of April 29, 2004, as amended (Non-Equity Securities), (ii) the base prospectus of Bayer Capital Corporation B.V. in respect of Non-Equity Securities, (iii) the base prospectus of Bayer Holding Ltd. in respect of Non-Equity Securities and (iv) the base prospectus of Bayer Nordic SE in respect of Non-Equity Securities (together, the Prospectus). BAYER AKTIENGESELLSCHAFT (incorporated in the Federal Republic of Germany) as Issuer and as Guarantor for Notes issued by BAYER CAPITAL CORPORATION B.V. (incorporated in the Netherlands) BAYER HOLDING LTD. (incorporated in Japan) BAYER NORDIC SE (incorporated in Finland) 15,000,000,000 Programme for the Issuance of Debt Instruments This Supplement has been approved by the Commission de Surveillance du Secteur Financier in its capacity as competent authority under the Luxembourg law of July 10, 2005 as amended relating to prospectuses for securities (Loi relative aux prospectus pour valeurs mobiliéres) (the Luxembourg Act), has been filed with said authority and will be published in electronic form (together with the documents incorporated by reference into this Supplement) on the website of the Luxembourg Stock Exchange (
2 Bayer Aktiengesellschaft (Bayer AG and together with its consolidated subsidiaries, the Bayer Group, Group or Bayer) with its registered office in Leverkusen, Germany, Bayer Capital Corporation B.V. (Bayer Capital Corp) with its registered office in Mijdrecht, The Netherlands, Bayer Holding Ltd. (Bayer Holding Ltd.) with its registered office in Tokyo, Japan and Bayer Nordic SE (Bayer Nordic) with its registered office in Espoo, Finland (each an Issuer and together the Issuers) are solely responsible for the information given in this Supplement. The Issuers accept responsibility for the information contained in this Supplement. To the best of the knowledge of the Issuers (which have taken all reasonable care to ensure that such is the case) the information contained in this Supplement is in accordance with the facts and does not omit anything likely to affect the import of such information. Terms defined or otherwise attributed meanings in the Prospectus have the same meaning in this Supplement. This Supplement is prepared for the purposes of amending and supplementing the information contained in the Prospectus. It shall only be distributed in connection with the Prospectus. To the extent that there is any inconsistency between any statement in this Supplement and any other statement in or incorporated by reference in the Prospectus, the statements in this Supplement will prevail. Save as disclosed on the pages 3 8 of this Supplement, there has been no other significant new factor, material mistake or inaccuracy relating to information included in the Prospectus which is capable of affecting the assessment of Notes issued under the Programme since the publication of the Prospectus. The Issuers have confirmed to the Dealers that the Prospectus as supplemented by this Supplement contains all information with regard to each Issuer and the Notes which is material in the context of the Programme and the issue and offering of Notes thereunder; that the information contained therein with respect to each Issuer and the Notes is accurate in all material respects and is not misleading; that any opinions and intentions expressed therein are honestly held and based on reasonable assumptions; that there are no other facts, the omission of which would make any statement, whether fact or opinion, in the Prospectus or this Supplement misleading in any material respect; and that all reasonable enquiries have been made to ascertain all facts and to verify the accuracy of all statements contained therein. No person has been authorised to give any information which is not contained in or not consistent with the Prospectus or this Supplement or any other information supplied in connection with the Programme and, if given or made, such information must not be relied upon as having been authorised by or on behalf of the Issuers or any of the Dealers. Neither the Arranger nor any Dealer nor any person mentioned in the Prospectus or this Supplement, excluding the Issuers, is responsible for the information contained in the Prospectus or this Supplement or any document incorporated therein by reference, and accordingly, and to the extent permitted by the laws of any relevant jurisdiction, none of these persons accepts any responsibility for the accuracy and completeness of the information contained in any of these documents. In accordance with Article 13 paragraph 2 of the Luxembourg Act, investors who have already agreed to purchase or subscribe for the Notes before this Supplement is published have the right, exercisable within a time limit of two working days after the publication of this Supplement, to withdraw their acceptances, provided that the new factor, mistake or inaccuracy referred to in Article 13 paragraph 1 of the Luxembourg Act arose before the final closing of the offer to the public and delivery of the Notes. The final date for the right of withdrawal will be August 2, v
3 Supplemental Information: 1. Changes relating to the Summary Section B Bayer AG a) Under Element B.12 (Selected historical key financial information) on page 3 of the Prospectus the following information shall be inserted at the beginning of the column: June 30, 2016 June 30, 2015 (a) in million Euro Sales 23,687 23,796 Net income (b) 2,891 2,498 Net cash flow (c) (d) 3,304 2,683 Total assets 75,474 75,663 Equity 24,035 22,466 (a) 2015 figures restated. As of December 31, 2015, Bayer Diabetes Care activities met the definition of discontinued operations according to IFRS 5 Non-current assets held for sale and discontinued operations. Accordingly, Diabetes Care business has been presented as discontinued operations in the period from January 1, 2016 to June 30, 2016 and in the respective comparative financial information in the consolidated financial statements of the Bayer Group. (b) Net income = Income (loss) after income taxes attributable to Bayer AG stockholders (c) Net cash flow = cash flow from operating activities according to IAS 7 (d) From continuing and discontinued operations Information extracted, without material adjustment, from the unaudited reviewed condensed consolidated interim financial statements of the Bayer Group as of and for the six months ended June 30, b) Under Element B.12 (Significant changes in the financial or trading position) on page 3 of the Prospectus the information shall be replaced by the following: B.12 Significant change in the financial or trading position Not applicable. There has been no significant change in the financial or trading position of the Bayer Group since the publication of the unaudited reviewed condensed consolidated interim financial statements as of and for the six months ended June 30, c) Under Element B.13 (Recent developments) on page 3 of the Prospectus the following text shall be inserted at the end of the column: Standard & Poor s gives Bayer a long-term issuer rating of A, while Moody s gives Bayer a long-term rating of A3. The short-term ratings are A-2 (Standard & Poor s) and P-2 (Moody s). Both rating agencies are currently reviewing these ratings with regard to a potential downgrade. 2. Changes relating to the Summary Section B Bayer Capital Corp a) Under Element B.12 (Selected historical key financial information) on page 5 of the Prospectus the following information shall be inserted at the beginning of the column: v
4 in thousand Euro Interest income 12,234 23,535 Income after taxes Net cash flow from operating activities 1,000 1,900 Total assets 603,357 1,601,124 Stockholder's equity 12,008 13,756 Information extracted, without material adjustment, from the unaudited unconsolidated interim financial statements of Bayer Capital Corp as of and for the six months ended June 30, b) Under Element B.12 (Significant changes in the financial or trading position) on page 5 of the Prospectus the information shall be replaced by the following: B.12 Significant change in the financial or trading position Not applicable. There has been no significant change in the financial or trading position of Bayer Capital Corp since the publication of the unaudited unconsolidated interim financial statements as of and for the six months ended June 30, Changes relating to the Summary Section B Bayer Holding Ltd. a) Under Element B.12 (Selected historical key financial information) on page 7 of the Prospectus the following information shall be inserted at the beginning of the column: in million Yen Total revenue 12,880 17,721 Net income after taxes 9,840 15,896 Net cash flow from operating activities 7,456 11,341 Total assets 222, ,249 Total net assets 92,958 88,700 Information extracted, without material adjustment, from the unaudited unconsolidated interim financial statements of Bayer Holding Ltd. as of and for the six months ended June 30, b) Under Element B.12 (Significant changes in the financial or trading position) on page 7 of the Prospectus the information shall be replaced by the following: B.12 Significant change in the financial or trading position Not applicable. There has been no significant change in the financial or trading position of Bayer Holding Ltd. since the publication of the unaudited unconsolidated interim financial statements as of and for the six months ended June 30, Changes relating to the Summary Section B Bayer Nordic a) Under Element B.12 (Selected historical key financial information) on page 9 of the Prospectus the following information shall be inserted at the beginning of the column: v
5 in thousand Euro Total revenue 5,057 5,800 Net income (loss) after taxes 409, ,906 Total assets 3,765,149 3,690,608 Stockholder's equity 1,707,948 1,332,625 Information extracted, without material adjustment, from the unaudited unconsolidated interim financial statements of Bayer Nordic as of and for the six months ended June 30, b) Under Element B.12 (Significant changes in the financial or trading position) on page 9 of the Prospectus the information shall be replaced by the following: B.12 Significant change in the financial or trading position Not applicable. There has been no significant change in the financial or trading position of Bayer Nordic since the publication of the unaudited unconsolidated interim financial statements as of and for the six months ended June 30, Changes relating to the section Bayer AG a) The following information shall be inserted as first paragraph under the heading Selected Financial Information on page 124 of the Prospectus: The following unaudited reviewed financial information was extracted, without material adjustment, from the unaudited reviewed condensed consolidated interim financial statements of the Bayer Group as of and for the six months ended June 30, June 30, 2016 June 30, 2015 (a) in million Euro Sales 23,687 23,796 Net income (b) 2,891 2,498 Net cash flow (c) (d) 3,304 2,683 Total assets 75,474 75,663 Equity 24,035 22,466 (a) 2015 figures restated. As of December 31, 2015, Bayer Diabetes Care activities met the definition of discontinued operations according to IFRS 5 Non-current assets held for sale and discontinued operations. Accordingly, Diabetes Care business has been presented as discontinued operations in the period from January 1, 2016 to June 30, 2016 and in the respective comparative financial information in the consolidated financial statements of the Bayer Group. (b) Net income = Income (loss) after income taxes attributable to Bayer AG stockholders (c) Net cash flow = cash flow from operating activities according to IAS 7 (d) From continuing and discontinued operations b) The paragraph under the heading Financial Information concerning the Issuer's Assets and Liabilities, Financial Position and Profit and Losses on page 140 of the Prospectus shall be replaced by the following: The consolidated financial statements of the Bayer Group as of and for the fiscal years ended December 31, 2015 and 2014, as of and for the three months ended on March 31, 2016 and as of and for the six months ended on June 30, 2016 are incorporated by reference into this Prospectus. Selected financial information appears in section Selected Financial Information v
6 c) The paragraph under the heading Significant Change in the Issuers' financial or trading position on page 147 of the Prospectus shall be replaced by the following: There has been no significant change in the financial or trading position of the Bayer Group since the publication of the unaudited reviewed condensed consolidated interim financial statements as of and for the six months ended June 30, d) The following information shall be inserted below the information under the heading Significant Change in the Issuers' financial or trading position on page 147 of the Prospectus: Recent developments Standard & Poor s gives Bayer a long-term issuer rating of A, while Moody s gives Bayer a long-term rating of A3. The short-term ratings are A-2 (Standard & Poor s) and P-2 (Moody s). Both rating agencies are currently reviewing these ratings with regard to a potential downgrade. 6. Changes relating to the section Bayer Capital Corporation B.V. a) The following information shall be inserted as first paragraph under the heading Selected Financial Information on page 150 of the Prospectus: The following unaudited financial information was extracted, without material adjustment, from the unaudited unconsolidated interim financial statements of Bayer Capital Corp as of and for the six months ended June 30, in thousand Euro Interest income 12,234 23,535 Income after taxes Net cash flow from operating activities 1,000 1,900 Total assets 603,357 1,601,124 Stockholder's equity 12,008 13,756 b) The paragraph under the heading Financial Information concerning the Issuer's Assets and Liabilities, Financial Position and Profit and Losses - Financial Statements on page 152 of the Prospectus shall be replaced by the following: The financial statements of Bayer Capital Corp as of and for the fiscal years ended December 31, 2014 and 2015, as of and for the three months ended on March 31, 2016 and as of and for the six months ended on June 30, 2016 are incorporated by reference into this Prospectus. Selected financial information appears in section Selected Financial Information. c) The paragraph under the heading Significant Change in financial or trading position on page 152 of the Prospectus shall be replaced by the following: There has been no significant change in the financial or trading position of Bayer Capital Corp since the publication of the unaudited unconsolidated interim financial statements as of and for the six months ended June 30, Changes relating to the section Bayer Holding Ltd. a) The following information shall be inserted as first paragraph under the heading Selected Financial Information on page 153 of the Prospectus: The following unaudited financial information was extracted, without material adjustment, from the unaudited unconsolidated interim financial statements of Bayer Holding Ltd. as of and for the six months ended June 30, v
7 in million Yen Total revenue 12,880 17,721 Net income after taxes 9,840 15,896 Net cash flow from operating activities 7,456 11,341 Total assets 222, ,249 Total net assets 92,958 88,700 b) The paragraph under the heading Financial Information concerning the Issuer's Assets and Liabilities, Financial Position and Profit and Losses - Financial Statements on page 155 of the Prospectus shall be replaced by the following: The financial statements of Bayer Holding Ltd. as of and for the fiscal years ended December 31, 2014 and 2015, as of and for the three months ended on March 31, 2016 and as of and for the six months ended on June 30, 2016 are incorporated by reference into this Prospectus. Selected financial information appears in section Selected Financial Information. c) The paragraph under the heading Significant Change in financial or trading position on page 155 of the Prospectus shall be replaced by the following: There has been no significant change in the financial or trading position of Bayer Holding Ltd. since the publication of the unaudited unconsolidated interim financial statements as of and for the six months ended June 30, Changes relating to the section Bayer Nordic SE a) The following information shall be inserted as first paragraph under the heading Selected Financial Information on page 157 of the Prospectus: The following unaudited financial information was extracted, without material adjustment, from the unaudited unconsolidated interim financial statements of Bayer Nordic as of and for the six months ended June 30, in thousand Euro Total revenue 5,057 5,800 Net income (loss) after taxes 409, ,906 Total assets 3,765,149 3,690,608 Stockholder's equity 1,707,948 1,332,625 b) The paragraph under the heading Financial Information concerning the Issuer's Assets and Liabilities, Financial Position and Profit and Losses - Financial Statements on page 159 of the Prospectus shall be replaced by the following: The financial statements of Bayer Nordic as of and for the fiscal years ended December 31, 2014 and 2015, as of and for the three months ended on March 31, 2016 and as of and for the six months ended on June 30, 2016 are incorporated by reference into this Prospectus. Selected financial information appears in section Selected Financial Information v
8 d) The paragraph under the heading Significant Change in financial or trading position on page 159 of the Prospectus shall be replaced by the following: There has been no significant change in the financial or trading position of Bayer Nordic since the publication of the unaudited unconsolidated interim financial statements as of and for the six months ended June 30, Changes relating to the section General Information The following text shall be inserted on page 180 of the Prospectus after paragraph 13 of GENERAL INFORMATION - Incorporation by Reference: 14. The unaudited reviewed condensed consolidated interim financial statements of the Bayer Group as of and for the six months ended on June 30, 2016 (the Group Q2 Interim Report) consisting of Income Statements (page 31 of the Group Q2 Interim Report), Statements of Comprehensive Income (page 32 of the Group Q2 Interim Report), Statements of Financial Position (page 33 of the Group Q2 Interim Report), Statements of Cash Flows (page 34 of the Group Q2 Interim Report), Statements of Changes in Equity (page 35 of the Group Q2 Interim Report), Notes (pages 36 to 52 of the Group Q2 Interim Report), Responsibility Statement (page 53 of the Group Q2 Interim Report), and Review Report (page 54 of the Group Q2 Interim Report). 15. The unaudited unconsolidated interim financial statements of Bayer Capital Corp as of and for the six months ended on June 30, 2016 (the BCC Q2 Interim Report) consisting of Balance Sheet (pages 5 to 6 of the BCC Q2 Interim Report), Profit and loss account (page 7 of the BCC Q2 Interim Report), Cash flow statement (pages 8 to 9 of the BCC Q2 Interim Report), Notes (pages 10 to 25 of the BCC Q2 Interim Report), and Responsibility Statement (page 28 of the BCC Q2 Interim Report). 16. The unaudited unconsolidated interim financial statements of Bayer Holding Ltd. as of and for the six months ended on June 30, 2016 (the BHL Q2 Interim Report) consisting of Balance Sheet (page 5 of the BHL Q2 Interim Report), Profit and Loss Statement (page 6 of the BHL Q2 Interim Report), Statement of Cash Flows (page 8 of the BHL Q2 Interim Report), Notes (pages 9 to 14 of the BHL Q2 Interim Report), and Responsibility Statement (page 15 of the BHL Q2 Interim Report). 17. The unaudited unconsolidated interim financial statements of Bayer Nordic as of and for the six months ended on June 30, 2016 (the BNSE Q2 Interim Report) consisting of Balance sheet (pages 4 of the BNSE Q2 Interim Report), Profit and loss statement (page 3 of the BNSE Q2 Interim Report), Notes (pages 5 to 9 of the BNSE Q2 Interim Report), and Responsibility Statement (page 10 of the BNSE Q2 Interim Report) v
Deutsche Telekom AG Bonn, Federal Republic of Germany as Issuer and as Guarantor for Notes issued by
Second Supplement dated 12 December 2012 to the Debt Issuance Programme Prospectus dated 3 May 2012 as supplemented by the First Supplement dated 12 October 2012 This document constitutes a supplement
More informationThird Supplement to the Debt Issuance Programme Prospectus dated 10 February 2015 Dated 19 August 2015
Third Supplement to the Debt Issuance Programme Prospectus dated 10 February 2015 Dated 19 August 2015 This document constitutes a supplement (the "Supplement") for the purposes of Article 16 of Directive
More informationVorarlberger Landes- und Hypothekenbank Aktiengesellschaft
First Supplement dated 21 October 2015 to the Prospectus dated 10 August 2015 This document constitutes a supplement (the "First Supplement") for the purposes of Article 13 of the Luxembourg Law on Prospectuses
More informationDeutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft (Frankfurt am Main, Germany) Programme for the issuance of Certificates, Warrants and Notes This document constitutes a supplement (the "Supplement") to the base prospectus
More informationDeutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft (Frankfurt am Main, Germany) Programme for the issuance of Certificates, Warrants and Notes This document constitutes a supplement (the "Supplement") to the base prospectus
More informationRaiffeisenlandesbank Oberösterreich Aktiengesellschaft
Fifth Supplement dated 29 October 2014 to the Debt Issuance Programme Prospectus dated 29 November 2013 This document constitutes a supplement (the "Fifth Supplement") for the purposes of Article 13 of
More informationDeutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft (Frankfurt am Main, Germany) Programme for the issuance of Notes, Certificates and Warrants This document constitutes a supplement (the "Supplement") to the base prospectus
More informationRAIFFEISEN ZENTRALBANK ÖSTERREICH AKTIENGESELLSCHAFT
Second Supplement dated 27 April 2015 to the Debt Issuance Programme Prospectus dated 30 September 2014 RAIFFEISEN ZENTRALBANK ÖSTERREICH AKTIENGESELLSCHAFT EUR 5,000,000,000 Debt Issuance Programme (the
More informationHYPO TIROL BANK AG. EUR 5,750,000,000 Debt Issuance Programme (the "Programme")
Third Supplement dated 29 December 2015 to the Prospectus dated 9 June 2015 This document constitutes a supplement (the "Third Supplement") within the meaning of Article 16 of the Directive 2003/71/EC
More informationF. van Lanschot Bankiers N.V. (incorporated in the Netherlands with its statutory seat in 's-hertogenbosch)
20 December 2012 FIFTH SUPPLEMENT TO THE BASE PROSPECTUS IN RESPECT OF THE EURO 5,000,000,000 DEBT ISSUANCE PROGRAMME F. van Lanschot Bankiers N.V. (incorporated in the Netherlands with its statutory seat
More informationHEWLETT-PACKARD COMPANY 2011 EMPLOYEE STOCK PURCHASE PLAN ( ESPP )
This prospectus supplement (the Prospectus Supplement ) is supplemental to, forms part of, and must be read in conjunction with the prospectus published by Hewlett-Packard Company ( HP or the Company )
More informationTHIRD PROSPECTUS SUPPLEMENT DATED 19 JANUARY 2012 TO THE BASE PROSPECTUS DATED 7 JUNE 2011 CAISSE D'AMORTISSEMENT DE LA DETTE SOCIALE
THIRD PROSPECTUS SUPPLEMENT DATED 19 JANUARY 2012 TO THE BASE PROSPECTUS DATED 7 JUNE 2011 CAISSE D'AMORTISSEMENT DE LA DETTE SOCIALE Établissement public national administratif (French national public
More informationSECOND PROSPECTUS SUPPLEMENT DATED 28 NOVEMBER 2012 TO THE BASE PROSPECTUS DATED 18 JUNE 2012 CAISSE D'AMORTISSEMENT DE LA DETTE SOCIALE
SECOND PROSPECTUS SUPPLEMENT DATED 28 NOVEMBER 2012 TO THE BASE PROSPECTUS DATED 18 JUNE 2012 CAISSE D'AMORTISSEMENT DE LA DETTE SOCIALE Établissement public national administratif (French national public
More informationSupplement No. 2 dated 25 September 2013 to the Base Prospectus for Equity linked Notes and Certificates dated 27 June 2013
Supplement No. 2 dated 25 September to the Base Prospectus for Equity linked Notes and Certificates dated 27 June MORGAN STANLEY & CO. INTERNATIONAL PLC (incorporated with limited liability in England
More informationBANCO BPI, S.A. (incorporated with limited liability in the Republic of Portugal) EUR 7,000,000,000 Euro Medium Term Note Programme
SUPPLEMENT DATED 8 th FEBRUARY 2016 TO THE PROSPECTUS DATED 13 th MARCH 2015 BANCO BPI, S.A. (incorporated with limited liability in the Republic of Portugal) EUR 7,000,000,000 Euro Medium Term Note Programme
More informationING Bank N.V. Certificates Programme
FOURTH SUPPLEMENT DATED 9 MAY 2014 UNDER THE CERTIFICATES PROGRAMME ING Bank N.V. (Incorporated in The Netherlands with its statutory seat in Amsterdam) Certificates Programme This Supplement (the Supplement
More informationInternational Personal Finance plc (incorporated with limited liability in England and Wales with registered number 06018973)
SUPPLEMENTARY PROSPECTUS DATED 27 AUGUST 2015 International Personal Finance plc (incorporated with limited liability in England and Wales with registered number 06018973) unconditionally and irrevocably
More informationSUPPLEMENT NUMBER 1 DATED 3 OCTOBER 2008 TO THE BASE PROSPECTUS DATED 23 SEPTEMBER 2008
SUPPLEMENT NUMBER 1 DATED 3 OCTOBER 2008 TO THE BASE PROSPECTUS DATED 23 SEPTEMBER 2008 Fortis Bank NV/SA (Incorporated as a public company with limited liability (Naamloze Vennootschap/Société Anonyme)
More informationSUPPLEMENT NUMBER 1 DATED 1 APRIL 2015 TO THE BASE PROSPECTUS DATED 21 AUGUST 2014
SUPPLEMENT NUMBER 1 DATED 1 APRIL 2015 TO THE BASE PROSPECTUS DATED 21 AUGUST 2014 ANHEUSER-BUSCH INBEV SA/NV (a public limited liability company with registered office at Grand-Place/Grote Markt 1, 1000
More informationING (US) ISSUANCE LLC REGISTRATION DOCUMENT
Dated 15 May 2009 ING (US) ISSUANCE LLC REGISTRATION DOCUMENT Table of Contents Page INTRODUCTION... 1 DOCUMENTS INCORPORATED BY REFERENCE... 3 RISK FACTORS... 4 DESCRIPTION OF ING (US) ISSUANCE LLC....
More information10,000,000,000 Debt Issuance Programme
Österreichische Volksbanken-Aktiengesellschaft (incorporated as a stock corporation in the Republic of ) Prospectus Supplement No. 5 relating to the 10,000,000,000 Debt Issuance Programme This supplement
More informationELECTRICITY SUPPLY BOARD (a body corporate established in Ireland under the Electricity (Supply) Acts 1927-2004 of Ireland)
OFFERING CIRCULAR SUPPLEMENT ELECTRICITY SUPPLY BOARD (a body corporate established in Ireland under the Electricity (Supply) Acts 1927-2004 of Ireland) ESB FINANCE LIMITED (a private company incorporated
More information7 IX. Equity (EEA Prospectus Directive) this is provisionally deleted pending review
ICMA PRIMARY MARKET HANDBOOK (IPMA HANDBOOK) Section Seven Standard Documentation & Standard Language 7 IX Standard Form Selling Restrictions A B Debt (UK) Equity (EEA Prospectus Directive) this is provisionally
More informationDebt Instruments Issuance Programme
SUPPLEMENT DATED 13 AUGUST 2014 TO THE BASE PROSPECTUS DATED 29 APRIL 2014 SOCIÉTÉ GÉNÉRALE as Issuer and Guarantor (incorporated in France) and SG ISSUER as Issuer (incorporated in Luxembourg) SGA SOCIÉTÉ
More informationS.A. 32,000,000,000 PROGRAMME FOR THE ISSUANCE OF DEBT INSTRUMENTS
BASE PROSPECTUS Santander International Debt, S.A. Unipersonal (incorporated with limited liability in Spain) and Santander Issuances, S.A. Unipersonal (incorporated with limited liability in Spain) guaranteed
More information!" #$ %& ' (# # # ) & ' (# # % * % + %% & ' (# #, % & ' % * % $) 1! - 4 4 2$$# #$#* '#"!'*#$)56 11
!"#"!" #$ %& ' (# # # ) & ' (# # % * % + %% & ' (# #, % & ' % * % $% $&'() -'. ""&'() &'()! "#$%&"#"'()$'$"$)$* +&' ( $($))#,*) /& + * *0(()!*))#$)# -.)!'&!/#0102$$##$#* '#"3*(#"#()*) $##$%*## $) 1! -
More informationJackson National Life Global Funding U.S. $8,000,000,000
BASE PROSPECTUS SUPPLEMENT Jackson National Life Global Funding U.S. $8,000,000,000 GLOBAL DEBT ISSUANCE PROGRAM This supplement (this Base Prospectus Supplement ) is supplemental to and must be read in
More informationEuro 10,000,000,000 Euro Medium Term Note Programme
FIRST SUPPLEMENT DATED 25 APRIL 2014 TO THE BASE PROSPECTUS DATED 9 OCTOBER 2013 Euro 10,000,000,000 Euro Medium Term Note Programme This first supplement (the First Supplement ) is supplemental to, and
More informationHow To Read A Georgesecraft.Com
General Electric Capital Corporation (Incorporated under the laws of the State of Delaware, United States of America) GE Capital Australia Funding Pty Ltd (A.B.N. 67085675467) (Incorporated with limited
More informationHaitong Investment Ireland p.l.c. Haitong Bank, S.A. Haitong Bank, S.A.
SUPPLEMENTARY OFFERING CIRCULAR DATED 7 OCTOBER 2015 Haitong Investment Ireland p.l.c. (incorporated with limited liability in Ireland and formerly Espírito Santo Investment p.l.c.) Haitong Bank, S.A.
More informationPART I GENERAL. Chapter 1. General provisions. Section 1. General scope of application of the Act
1(49) Unofficial translation Amendments up to 258/2013 included 746/2012 Issued in Helsinki on 14 December 2012 Securities Markets Act Pursuant to the decision of Parliament, the following is enacted:
More informationBANCA IMI S.p.A. CREDIT LINKED CERTIFICATES PROGRAMME
BASE PROSPECTUS BANCA IMI S.p.A. (incorporated with limited liability in the Republic of Italy) CREDIT LINKED CERTIFICATES PROGRAMME Under the terms of its Credit Linked Certificates Programme (the Programme),
More informationRoche Capital Market Ltd Interim Financial Statements 2014
Roche Capital Market Ltd Interim Financial Statements 2014 Roche Capital Market Ltd Interim Financial Statements The Interim Financial Statements have been reviewed by Roche Capital Market Ltd s auditor
More informationDeutsche Bank Aktiengesellschaft
SIXTH SUPPLEMENT DATED 27 MAY 2015 TO THE BASE PROSPECTUS DATED 26 JUNE 2014 AS SUPPLEMENTED BY THE FIRST SUPPLEMENT DATED 1 AUGUST 2014 THE SECOND SUPPLEMENT DATED 17 NOVEMBER 2014 THE THIRD SUPPLEMENT
More informationBANCA IMI S.p.A. CERTIFICATES PROGRAMME
FIRST SUPPLEMENT DATED 19 OCTOBER 2015 TO THE BASE PROSPECTUS DATED 21 JULY 2015 BANCA IMI S.p.A. (incorporated with limited liability in the Republic of Italy) CERTIFICATES PROGRAMME This first supplement
More informationak åsåietåååi'råti AGENCE FRANçAISE DE DÉVELOPPEMENT EURO 25,000,000,000
V.AFD 22.07.13 FIRST PROSPECTUS SUPPLEMENT DÄTED [23] JULY 2013 TO THE BASE PROSPECTUS DATED 19 JUNE 2OI3 ak åsåietåååi'råti AGENCE FRANçAISE DE DÉVELOPPEMENT EURO 25,000,000,000 Euro Medium Term Note
More informationSiem Offshore Inc. Supplementing information contained in the Prospectus dated 17 August 2015 concerning the Rights Issue in Siem Offshore Inc.
Siem Offshore Inc. Supplementing information contained in the Prospectus dated 17 August 2015 concerning the Rights Issue in Siem Offshore Inc. This document (the Supplemental Prospectus ) is a supplement
More informationStructured Note Programme
BASE PROSPECTUS Dated 26 June 2012 UNICREDIT S.p.A. (incorporated with limited liability as a Società per Azioni in the Republic of Italy under registered number 00348170101) and UNICREDIT BANK IRELAND
More informationClose Brothers Close Brothers Finance plc (incorporated with limited liability in England and Wales with registered number 4322721)
SUPPLEMENTARY PROSPECTUS DATED 9 APRIL Close Brothers Close Brothers Finance plc (incorporated with limited liability in England and Wales with registered number 4322721) 1,000,000,000 Euro Medium Term
More informationSECOND SUPPLEMENT TO THE BASE PROSPECTUS DATED 18 DECEMBER 2014
Deutsche Bank Aktiengesellschaft (Frankfurt am Main, Germany) Programme for the issuance of Certificates, Warrants and Notes This document constitutes a supplement (the "Supplement") to the base prospectus
More informationDeutsche Bank Capital Funding Trust XI Wilmington, Delaware, United States of America (a wholly owned subsidiary of Deutsche Bank Aktiengesellschaft)
Prospectus 21 August 2009 Deutsche Bank Capital Funding Trust XI Wilmington, Delaware, United States of America (a wholly owned subsidiary of Deutsche Bank Aktiengesellschaft) [ ] [ ]% Non-cumulative Trust
More informationSUMMARY Belfius Financing Company (LU) NOK Step Up 2 due 7 April 2020
SUMMARY Belfius Financing Company (LU) NOK Step Up 2 due 7 April 2020 The following summary is established in accordance with Articles 24 and 28 of the Belgian Law of 16 June 2006 on the public offer of
More information350,000,000 Non-cumulative Trust Preferred Securities (Liquidation Preference Amount of 50,000 per Trust Preferred Security)
Hypo Real Estate International Trust I Wilmington, Delaware, United States of America (a wholly-owned subsidiary of Hypo Real Estate Bank International AG, Stuttgart, Federal Republic of Germany) 350,000,000
More informationListing and Admission to Trading Rules for. Short Term Paper. Release 2
Listing and Admission to Trading Rules for Short Term Paper Release 2 14 April 2014 Scope These Listing and Admission to Trading Rules ( Rules ) relate to the Listing and admission to trading on the Main
More informationFOURTH SUPPLEMENT TO THE BASE PROSPECTUS IN RESPECT OF THE STRUCTURED PRODUCTS PROGRAMME FOR THE ISSUANCE OF NOTES ABN AMRO BANK N.V.
27 June FOURTH SUPPLEMENT TO THE BASE PROSPECTUS IN RESPECT OF THE STRUCTURED PRODUCTS PROGRAMME FOR THE ISSUANCE OF NOTES ABN AMRO BANK N.V. (Registered at Amsterdam, The Netherlands) ABN AMRO Structured
More informationThird Supplement dated 8 September 2015 to the Euro Medium Term Note Programme Base Prospectus dated 12 December 2014
Third Supplement dated 8 September 2015 to the Euro Medium Term Note Programme Base Prospectus dated 12 December 2014 HSBC France 20,000,000,000 Euro Medium Term Note Programme This third supplement (the
More informationAutomatic Data Processing, Inc. and Subsidiaries Consolidated Statements of Earnings (In millions, except per share amounts) (Unaudited)
Automatic Data Processing, Inc. and Subsidiaries Consolidated Statements of Earnings (In millions, except per share amounts) (Unaudited) 2006 (B) 2005 (C) 2006 (B) 2005 (C) Revenues, other than interest
More informationDeutsche Bank AG fully and unconditionally guarantees, on a subordinated basis, payments in respect of the Trust Preferred Securities.
Prospectus 2 May 2008 Deutsche Bank Contingent Capital Trust IV Wilmington, Delaware, United States of America (a wholly owned subsidiary of Deutsche Bank Aktiengesellschaft) [ ] [ ]% Trust Preferred Securities
More informationBANCA IMI S.p.A. CERTIFICATES PROGRAMME
BASE PROSPECTUS BANCA IMI S.p.A. (incorporated with limited liability in the Republic of Italy) CERTIFICATES PROGRAMME Under the terms of its Certificates Programme (the "Programme"), Banca IMI S.p.A.
More informationIMPORTANT NOTICE IMPORTANT: You must read the following before continuing. Base Prospectus SECURITIES ACT Confirmation of your Representation: QIBs
IMPORTANT NOTICE THIS BASE PROSPECTUS IS AVAILABLE ONLY TO (1) QUALIFIED INSTITUTIONAL BUYERS WHO ARE ALSO QUALIFIED PURCHASERS (EACH DEFINED BELOW) OR (2) CERTAIN PERSONS OUTSIDE OF THE U.S. IMPORTANT:
More informationFINANCIAL STATEMENTS. BNZ Cash PIE and BNZ Term PIE
FINANCIAL STATEMENTS BNZ Cash PIE and BNZ Term PIE Financial Statements for the year ended Directory The Manager BNZ Investment Services Limited Level 4 80 Queen Street Auckland 1010 Private Bag 92208
More informationKBC IFIMA S.A. (Incorporated with limited liability in the Grand Duchy of Luxembourg) Unconditionally and irrevocably guaranteed by KBC Bank NV
RETAIL BASE PROSPECTUS KBC IFIMA S.A. (Incorporated with limited liability in the Grand Duchy of Luxembourg) Unconditionally and irrevocably guaranteed by KBC Bank NV (Incorporated with limited liability
More informationThis Supplement supersedes and replaces the Supplement dated 16 th September, 2005.
CONFORMED COPY SUPPLEMENT dated 20 th September, 2005 To the Debt Issuance Programme Prospectus of SOCIÉTÉ GÉNÉRALE (incorporated in France) and SGA SOCIÉTÉ GÉNÉRALE ACCEPTANCE N.V. (incorporated in The
More informationLEHMAN BROTHERS TREASURY CO. B.V. (incorporated with limited liability in The Netherlands and having its statutory domicile in Amsterdam)
SUMMARY NOTE dated 8 August 2008 LEHMAN BROTHERS TREASURY CO. B.V. (incorporated with limited liability in The Netherlands and having its statutory domicile in Amsterdam) Issue of up to EUR 25,000,000
More informationBANCA IMI S.p.A. (incorporated with limited liability in the Republic of Italy) Structured Note Programme
BANCA IMI S.p.A. (incorporated with limited liability in the Republic of Italy) Structured Note Programme Under this Structured Note Programme (the Programme) Banca IMI S.p.A. (the Issuer) may from time
More informationBROKERCREDITSERVICE STRUCTURED PRODUCTS PLC (incorporated in Cyprus) (as Issuer)
BASE PROSPECTUS SUPPLEMENT BROKERCREDITSERVICE STRUCTURED PRODUCTS PLC (incorporated in Cyprus) (as Issuer) EUR 10,000,000,000 EURO MEDIUM TERM NOTE PROGRAMME BrokerCreditService Structured Products plc
More informationBANCO BPI, S.A. (incorporated with limited liability in the Republic of Portugal) EUR 7,000,000,000 Euro Medium Term Note Programme
SUPPLEMENT DATED 5 th JANUARY 2016 TO THE PROSPECTUS DATED 13 th MARCH 2015 BANCO BPI, S.A. (incorporated with limited liability in the Republic of Portugal) EUR 7,000,000,000 Euro Medium Term Note Programme
More informationING Bank N.V. Issue of 500,000 Long Share Open Ended Turbo linked to Ordinary Shares of PGE SA under the Certificates Programme
Final Terms dated 17 June 2013 ING Bank N.V. Issue of 500,000 Long Share Open Ended Turbo linked to Ordinary Shares of PGE SA under the Certificates Programme The Base Prospectus referred to below (as
More informationInternational Financial Reporting Standards (IFRS)
FACT SHEET September 2011 IAS 27 Consolidated and separate financial statements (This fact sheet is based on the standard as at 1 January 2011.) Important note: This fact sheet is based on the requirements
More informationSPECIAL PURPOSE ENTITIES
SPECIAL PURPOSE ENTITIES TECHNICAL COMMITTEE OF THE INTERNATIONAL ORGANIZATION OF SECURITIES COMMISSIONS APRIL 2007 2 Introduction In its 2005 report entitled Strengthening Capital Markets Against Financial
More information7. (a) Place and Method of Offering / (b) Offer price of the Bonds:
FOR RELEASE: September 2, 2004 Notice Concerning Issuance of Euro Yen Convertible Bonds due 2011 (convertible bonds type - bonds with stock acquisition rights, tenkanshasaigata shinkabu yoyakuken-tsuki
More information13 March 2014 PART A CONTRACTUAL TERMS
13 March 2014 VOLVO TREASURY AB (publ) (the Issuer ) Issue of SEK 1,750,000,000 Fixed Rate Notes due 17 March 2016 guaranteed by AB Volvo (publ) (the Guarantor ) issued pursuant to the U.S.$15,000,000,000
More informationOLD MUTUAL LIFE ASSURANCE COMPANY (SOUTH AFRICA) LIMITED
APPLICABLE PRICING SUPPLEMENT OLD MUTUAL LIFE ASSURANCE COMPANY (SOUTH AFRICA) LIMITED (Incorporated in the Republic of South Africa with limited liability under registration number 1999/004643/06) Issue
More informationAPPLICABLE FINAL TERMS
APPLICABLE FINAL TERMS 10 May 2016 CNH INDUSTRIAL FINANCE EUROPE S.A. Issue of 500,000,000 2.875 per cent. Notes due 17 May 2023 Guaranteed by CNH Industrial N.V. under the 10,000,000,000 Global Medium
More informationFINANCIAL SUPPLEMENT December 31, 2015
FINANCIAL SUPPLEMENT December 31, 2015 Monster Worldwide, Inc. (together with its consolidated subsidiaries, the Company, Monster, we, our or us ) provides this supplement to assist investors in evaluating
More informationCHF25,000,000 Class H-7C1 Fairway Series 1 (Omega Capital Europe p.l.c. Series 23) Secured 5 per cent Notes due 2013 Issue price: 100 per cent.
PROSPECTUS DATED 17 JANUARY 2008 OMEGA CAPITAL EUROPE P.L.C. (a public limited company incorporated in Ireland) CHF25,000,000 Class H-7C1 Fairway Series 1 (Omega Capital Europe p.l.c. Series 23) Secured
More informationThe Royal Bank of Scotland plc
5 October 2011 The Royal Bank of Scotland plc (Incorporated in Scotland with limited liability under the Companies Acts 1948 to 1980, registered number SCO90312) 200 Put Warrants linked to the performance
More informationETFX FUND COMPANY PUBLIC LIMITED COMPANY
The Company and the Directors, whose names appear on page 131 of the Prospectus, are the persons responsible for the information contained in this Fund Supplement and accept responsibility accordingly.
More informationCITIGROUP INC. (incorporated in Delaware) the issuer under the Citi U.S.$10,000,000,000 Global Structured Note Programme
Structured Note Programme Base Prospectus dated 26 June 2013 CITIGROUP INC. (incorporated in Delaware) the issuer under the Citi U.S.$10,000,000,000 Global Structured Note Programme Under the Citi U.S.$10,000,000,000
More informationTAURUS CAPITAL SA. Limited Recourse Securities Programme
BASE PROSPECTUS TAURUS CAPITAL SA. (a public limited liability company (société anonyme) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 19, rue de Bitbourg
More informationNeither the Issuer nor any Dealer has authorised, nor do they authorise, the making of any offer of Notes in any other circumstances.
Final Terms dated 20 May 2011 ING Bank N.V. Issue of a minimum of EUR 25,000,000 5 Year Floored Floater Notes due June 2016 issued pursuant to a 50,000,000,000 Global Issuance Programme The Base Prospectus
More informationMalachite Funding Limited (incorporated with limited liability in the Cayman Islands) U.S.$5,000,000,000 Income Note Programme
IMPORTANT NOTICE The information contained in the electronic copy of the Base Prospectus attached hereto has been formatted in a manner which should exactly replicate the printed Base Prospectus; however,
More informationSUPPLEMENTARY PROSPECTUS
BANK OF CYPRUS PUBLIC COMPANY LIMITED (The Company was founded in Cyprus under the Cyprus Companies Law, Cap. 113) (Company Registration no: ΗΕ165) SUPPLEMENTARY PROSPECTUS DATE: 2 June 2011 In compliance
More informationFilings With the U.S. Securities and Exchange Commission Under the Securities Act of 1933
Filings With the U.S. Securities and Exchange Commission 1073 AU-C Section 925 Filings With the U.S. Securities and Exchange Commission Under the Securities Act of 1933 Source: SAS No. 122. Effective for
More informationUnione di Banche Italiane S.p.A. (formerly Unione di Banche Italiane S.c.p.a.)
SECOND SUPPLEMENT DATED 19 OCTOBER 2015 TO THE BASE PROSPECTUS DATED 30 JULY 2015 Unione di Banche Italiane S.p.A. (formerly Unione di Banche Italiane S.c.p.a.) (incorporated as a joint stock company in
More informationSUPPLEMENT. To BASE PROSPECTUS. for Certificates
SUPPLEMENT To BASE PROSPECTUS for Certificates Deutsche Bank AG [London] [Up to] [Quantity] Certificates [each WKN/ISIN] relating to [insert details of the Underlying] Issued under its TM Programme This
More informationBASF SE BASF Finance Europe N.V.
First Supplement Dated March 1, 2016 to the Debt Issuance Program Prospectus Dated September 15, 2015 BASF SE BASF Finance Europe N.V. Euro 20,000,000,000 Debt Issuance Program (the "Program") First supplement
More informationDTS CORPORATION and Consolidated Subsidiaries. Unaudited Quarterly Consolidated Financial Statements for the Three Months Ended June 30, 2008
DTS CORPORATION and Consolidated Subsidiaries Unaudited Quarterly Consolidated Financial Statements for the Three Months Ended June 30, 2008 DTS CORPORATION and Consolidated Subsidiaries Quarterly Consolidated
More informationThis Information Memorandum has been prepared for use only in connection with Securities issued by the Issuer.
INFORMATION MEMORANDUM dated 4 November 2015 Argon Capital Public Limited Company (incorporated with limited liability in Ireland under registered number 351104) U.S.$50,000,000,000 Limited Recourse Secured
More information296,450,000 million Convertible Bonds due 2016 Convertible into Ordinary Bearer Shares of Salzgitter AG
This is not an offering memorandum or offering circular or prospectus and should not be treated as offering material of any sort and is for information purposes only. NOT FOR DISTRIBUTION IN OR TO THE
More informationHalf - Year Financial Report January June 2015
Deutsche Bank Capital Finance Trust I (a statutory trust formed under the Delaware Statutory Trust Act with its principle place of business in New York/New York/U.S.A.) Half - Year Financial Report January
More informationNon-collateralised Structured Products Supplemental Listing Document for Warrants over Index
27 January 2016 Hong Kong Exchanges and Clearing Limited ( HKEx ), The Stock Exchange of Hong Kong Limited (the Stock Exchange ) and Hong Kong Securities Clearing Company Limited take no responsibility
More informationOLD MUTUAL LIFE ASSURANCE COMPANY (SOUTH AFRICA) LIMITED
APPLICABLE PRICING SUPPLEMENT OLD MUTUAL LIFE ASSURANCE COMPANY (SOUTH AFRICA) LIMITED (Incorporated in the Republic of South Africa with limited liability under registration number 1999/004643/06) Issue
More informationBANCA IMI S.p.A. WARRANT AND CERTIFICATE PROGRAMME
BASE PROSPECTUS BANCA IMI S.p.A. (incorporated with limited liability in the Republic of Italy) WARRANT AND CERTIFICATE PROGRAMME Under the terms of its Warrant and Certificate Programme (the Programme),
More informationOverview of the key figures for the first half of the year
Half-Year Report 2015 Q2 Revenues increase in the first half of the year by 23% EBIT increased by 1.5 million euros compared to the previous year Order book is growing Overall annual forecast remains unchanged
More information2018-04 SEK ING Sprinter Sverige ING Bank NV (NL) 20 Units Outperformance Bonus Certificates linked to OMX due 2018-04
2018-04 SEK ING Sprinter Sverige ING Bank NV (NL) 20 Units Outperformance Bonus Certificates linked to OMX due 2018-04 Product Description This 5YR SEK Outperformance Bonus Certificate is linked to the
More informationFREEDOM INVESTMENTS, INC. STATEMENT OF FINANCIAL CONDITION AS OF JUNE 30, 2015 (UNAUDITED)
FREEDOM INVESTMENTS, INC. STATEMENT OF FINANCIAL CONDITION AS OF JUNE 30, 2015 (UNAUDITED) ****** Index Page(s) Statement of Financial Condition. 2 Notes to Statement of Financial Condition. 3-5 Statement
More informationWhere to List Bonds Issued in the International Markets by Asian Corporates?
May 2012 BRIEFING NOTE Where to List Bonds Issued in the International Markets by Asian Corporates? Introduction In this briefing note we highlight some of the factors which determine the choice of listing
More informationListing of Shares on the Luxembourg Stock Exchange
Listing of Shares on the Luxembourg Stock Exchange The firm in brief Elvinger, Hoss & Prussen, leaders in their fields since 1964, has broad experience of working on all kinds of capital market transactions
More informationPreparation of Pro Forma Financial Information for Inclusion in Investment Circulars
AG 7 Issued March 2006 Effective for engagements where the investment circular is dated on or after 1 April 2006 Accounting Guideline 7 Preparation of Pro Forma Financial Information for Inclusion in Investment
More informationInterim Consolidated Financial Statements (Unaudited)
Interim Consolidated Financial Statements (Unaudited) For the Six Months Ended, NTT FINANCE CORPORATION This document has been translated and reclassified from a part of the Japanese
More informationGlaxoSmithKline plc (incorporated in England and Wales with limited liability under registered number 3888792)
REGISTRATION DOCUMENT (incorporated in England and Wales with limited liability under registered number 3888792) GlaxoSmithKline Capital Inc. (incorporated in the State of Delaware with limited liability
More informationSUPPLEMENT N 4 DATED 12 May 2014 TO THE BASE PROSPECTUS DATED 22 NOVEMBER 2013. BPCE Euro 40,000,000,000 Euro Medium Term Note Programme
SUPPLEMENT N 4 DATED 12 May 2014 TO THE BASE PROSPECTUS DATED 22 NOVEMBER 2013 BPCE Euro 40,000,000,000 Euro Medium Term Note Programme BPCE (the Issuer ) may, subject to compliance with all relevant laws,
More informationConsolidated Financial Summary under IFRS for the fiscal year ending March 31, 2015 (April 1, 2014 - March 31, 2015)
Monex Group, Inc. Consolidated Financial Summary under IFRS for the fiscal year 2015 (April 1, 2014 - March 31, 2015) This is an English translation of Japanese report of the consolidated financial summary
More informationCLOUD SECURITY CORP.
SECURITIES & EXCHANGE COMMISSION EDGAR FILING CLOUD SECURITY CORP. Form: 10-Q Date Filed: 2015-10-09 Corporate Issuer CIK: 1516079 Copyright 2015, Issuer Direct Corporation. All Right Reserved. Distribution
More information(Incorporated as a stock corporation in the Republic of Austria under registered number FN 33209 m)
Prospectus Supplement No. 2 Erste Group Bank AG (Incorporated as a stock corporation in the Republic of Austria under registered number FN 33209 m) EUR 30,000,000,000 Debt Issuance Programme This supplement
More informationSTANDING ADVISORY GROUP MEETING
1666 K Street, NW Washington, D.C. 20006 Telephone: (202) 207-9100 Facsimile: (202)862-8430 www.pcaobus.org STANDING ADVISORY GROUP MEETING BROKER-DEALER AUDIT CONSIDERATIONS JULY 15, 2010 Introduction
More informationTelstra Corporation Limited (ABN 33 051 775 556) (incorporated with limited liability in the Commonwealth of Australia)
PROSPECTUS Telstra Corporation Limited (ABN 33 051 775 556) (incorporated with limited liability in the Commonwealth of Australia) 15,000,000,000 Debt Issuance Program Telstra Corporation Limited ( Issuer
More informationGLADIATOR MINERALS INC. INTERIM FINANCIAL STATEMENTS MARCH 31, 2001. (Unaudited prepared by management)
INTERIM FINANCIAL STATEMENTS MARCH 31, 2001 INTERIM BALANCE SHEETS FOR THE THREE MONTH PERIOD ENDED MARCH 31 March 31 2001 December 31 2000 ASSETS Current Cash $ 28 $ - Receivables - - Marketable securities
More informationFinancial Report Annual Financial Report 2015
Deutsche Postbank Funding Trust IV (a statutory trust formed under the Delaware Statutory Trust Act with its principal place of business in New York, NY, U.S.A.) Financial Report Annual Financial Report
More information